Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 81 - 100 out of 500 displayed.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Syapse Announces Research Using Real-World Evidence at ASCO20 Virtual

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Syapse, Inc.

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

Read more ››
By: GlobenewsWire - 29 May 2020

Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics

Read more ››
By: GlobenewsWire - 29 May 2020

BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenström’s Macroglobulinemia at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  BeiGene, Ltd.

electroCore, Inc. to Present at Little Grapevine’s G1 Microcap Virtual Conference

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  electroCore LLC

RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  RAPT Therapeutics

Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing Glioma

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Agios Pharmaceuticals, Inc.

Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Novan, Inc.

Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Bio-Path Holdings, Inc.

Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC® HPN424 at the ASCO20 Virtual Scientific Program

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Harpoon Therapeutics, Inc.

Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Galera Therapeutics, Inc.

eFFECTOR’s Tomivosertib Demonstrates Positive Phase 2 Results for Subjects with Non-Small Cell Lung Cancer in Combination with Checkpoint Inhibitors

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Effector Therapeutics, Inc.

Trillium Therapeutics Provides Update on the Phase I Dose Escalation Study of Its CD47 Blocker TTI-622 at the ASCO20 Virtual Scientific Program

Read more ››
By: GlobenewsWire - 29 May 2020

Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Corvus Pharmaceuticals, Inc.

BeiGene Presents Phase 3 Data on Tislelizumab Combined with Chemotherapy for the Treatment of Patients with Advanced Squamous Non-Small Cell Lung Cancer at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  BeiGene, Ltd.

Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at ASCO20 Virtual Annual Meeting

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Calithera Biosciences, Inc.

Genocea Presents Updated Long-term Safety, Immunogenicity and Durability Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial Part A at Virtual ASCO 2020

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Genocea Biosciences, Inc.

Iovance Presents Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at ASCO Scientific Program

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Iovance Biotherapeutics, Inc.

CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  CytomX Therapeutics, Inc.

Affimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 Virtual Meeting

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Affimed N.V.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑